Seattle Genetics To Resume Trials As FDA Lifts Clinical Hold
March 06, 2017 | Seattle Genetics said on Monday the U.S. Food and Drug Administration lifted a clinical hold on several early stage studies testing its experimental cancer drug. Reuters
March 06, 2017 | Seattle Genetics said on Monday the U.S. Food and Drug Administration lifted a clinical hold on several early stage studies testing its experimental cancer drug. Reuters
